| 000 | 01344 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517141600.0 | ||
| 264 | 0 | _c20170418 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1469-0691 | ||
| 024 | 7 |
_a10.1016/j.cmi.2017.02.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPogue, J M | |
| 245 | 0 | 0 |
_aClinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing. _h[electronic resource] |
| 260 |
_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cApr 2017 |
||
| 300 |
_a229-233 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aColistin _xadministration & dosage |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aPolymyxins _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aOrtwine, J K | |
| 700 | 1 | _aKaye, K S | |
| 773 | 0 |
_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 23 _gno. 4 _gp. 229-233 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cmi.2017.02.023 _zAvailable from publisher's website |
| 999 |
_c26915250 _d26915250 |
||